BioSurfaces, LLC develops medical devices, coatings, 3D tissue engineering scaffolds, and drug delivery systems using proprietary electrospinning technology with FDA-approved polymers. The company serves the medical, pharmaceutical, and research sectors by providing nanofibrous materials designed to encourage healing, treat diseases, and support in vitro research.
Subscribe to see BioSurfaces, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BioSurfaces, LLC is a medical devices & biotechnology company headquartered in United States. Its most recent funding round raised $900,000 in March 2018. Xcout tracks 12 named people at BioSurfaces, LLC, including Thomas L Barrette (Chief Legal Officer Vice President, Strategy).
6 more named people on record for BioSurfaces, LLC, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $900,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of BioSurfaces, LLC's closest competitors — see the full list of competitors and alternatives →
3-D Matrix, Ltd. specializes in pioneering self-assembling peptide technology. Its flagship product, PuraMatrix, is an innovative self-assembling peptide hydrogel with diverse applications across medical fields, including regenerative medicine, cell therapy, advanced drug delivery systems, and surgical interventions. This Tokyo-based firm was established in 2004.
BioWound Solutions, LLC provides advanced wound management products and dressings, including collagen technologies, antimicrobial protections, and moisture-balancing solutions. The company serves healthcare providers, clinicians, and organizations by supplying medical products designed to promote wound healing and clinical efficiency.
Orbio Health Inc. (Orbio Innovations) provides research, development, and consulting services specializing in orthobiologics, biomaterials, and medical devices. The company serves orthopedic and spinal hardware companies by developing innovative bone grafting and soft tissue repair solutions, including enhanced allograft technology, collagen and ceramic biomaterials, and 3-D printed designs.
SurgaColl is an Irish medical-device company developing collagen-based biomaterial scaffolds for regenerative medicine and tissue repair. Its products are intended for use by healthcare professionals treating patients who need tissue regeneration, including bone or soft-tissue repair.
BioSculpture Technology, Inc. develops and manufactures medical devices and surgical instruments, specializing in advanced power-assisted dual-cannula tissue aspiration systems. The company serves physicians in the liposuction, body sculpting, bariatric treatment, and fat autograft and stem cell processing markets.
PolyNovo Limited develops and manufactures synthetic skin substitutes using its proprietary NovoSorb technology. The company provides medical products designed to support wound management and natural healing for healthcare professionals and patients.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.